TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16899425

Group type: EXPERIMENTAL
Intervention: Fumaric acid esters (FAE's, Fumaderm) at a maximum dose of 120 mg dimethylfumarate per day for six months
Number of subjects: 10
Study: 16186995

Group type: EXPERIMENTAL
Intervention: Parenteral nutrition supplemented with 0.57 g/kg glutamine‐dipeptide
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 12540411

Group type: EXPERIMENTAL
Intervention: Low-fat high-carbohydrate (LF-HC) diet
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High-fat low-carbohydrate (HF-LC) diet
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: High-fructose diet
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 36
Study: 9894690

Group type: EXPERIMENTAL
Intervention: Curvature discrimination along the middle finger orientation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Curvature discrimination across the middle finger orientation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Influence of surface shape on curvature perception
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discrimination orientation influence
Number of subjects: 0
Study: 7485933

Group type: EXPERIMENTAL
Intervention: ondansetron 150 micrograms/kg (Group A)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: ondansetron 75 micrograms/kg (Group B)
Number of subjects: 213

Group type: COMPARATOR
Intervention: droperidol 75 micrograms/kg (Group C)
Number of subjects: 213
Study: 2386281

Group type: EXPERIMENTAL
Intervention: Heat and moisture exchanger (n = 20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No artificial humidification (n = 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Heated humidifier (n = 20)
Number of subjects: 60
Study: 7353349

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 6

Group type: COMPARATOR
Intervention: Inactivity
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Randomized physical activity
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Heart rate changes during randomized periods
Number of subjects: 6
Study: 12047839

Group type: EXPERIMENTAL
Intervention: Culturally relevant nutrition education intervention delivered by bicultural, bilingual Vietnamese‐American nutrition education assistants, consisting of 5 to 7 lessons over an 8-week period.
Number of subjects: 152

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Culturally relevant nutrition education intervention
Number of subjects: 152
Study: 30112275

Group type: EXPERIMENTAL
Intervention: Neurofeedback targeting the ipsilesional primary motor cortex
Number of subjects: 10

Group type: COMPARATOR
Intervention: Neurofeedback training of a control brain area
Number of subjects: 10
Study: 27982402

Group type: EXPERIMENTAL
Intervention: Ice pack associated with antipyretic
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Warm compress associated with antipyretic
Number of subjects: 102

Group type: COMPARATOR
Intervention: Antipyretic (Control)
Number of subjects: 102
Study: 24399100

Group type: EXPERIMENTAL
Intervention: Conventional services (17.8 hours/week for ASD vs 11 hours/week for DD)
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Complementary and alternative medicine (CAM)
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Psychotropic medications
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Parental education level
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Conventional services (>20 hours/week)
Number of subjects: 578

Group type: EXPERIMENTAL
Intervention: Immunization status
Number of subjects: 578
Study: 22227067

Group type: EXPERIMENTAL
Intervention: Social Cognitive Theory constructs (nutrition‐related self‐efficacy, intention, behavioral strategies, family support, situation, outcome expectations, and outcome expectancies)
Number of subjects: 357

Group type: EXPERIMENTAL
Intervention: Social Cognitive Theory constructs
Number of subjects: 357
Study: 20718310

Group type: EXPERIMENTAL
Intervention: Dental intervention directed at pregnant women
Number of subjects: 0
Study: 18620511

Group type: EXPERIMENTAL
Intervention: Chloroquine treatment (600 mg at day 1, 600 mg at days 2 and 3, 300 mg at days 4 and 5)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 54
Study: 16094063

Group type: EXPERIMENTAL
Intervention: 1 ml/kg 0.125% bupivacaine with 1 microg/kg clonidine
Number of subjects: 35

Group type: COMPARATOR
Intervention: 1 ml/kg 0.125% bupivacaine (controls)
Number of subjects: 35
Study: 12165122

Group type: EXPERIMENTAL
Intervention: Combined phototherapy and low-intensity laser therapy (LILT) with parameters: 532 mW; 5 kHz; 12 J/cm² for 4 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (sham treatments)
Number of subjects: 15
Study: 9933035

Group type: EXPERIMENTAL
Intervention: TUMT plus tamsulosin (0.4 mg daily)
Number of subjects: 81

Group type: COMPARATOR
Intervention: TUMT alone
Number of subjects: 81
Study: 7772590

Group type: EXPERIMENTAL
Intervention: Orthoptic exercises/treatment
Number of subjects: 52

Group type: COMPARATOR
Intervention: Monitoring for signs of spontaneous recovery
Number of subjects: 52
Study: 2177647

Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogens 1.25 mg daily + dydrogesterone 20 mg daily for 12 days during months 2, 3, and 4, then 10 mg daily for the same duration in months 5, 6, and 7
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogens 1.25 mg daily + dydrogesterone (two doses in reverse sequence)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Conjugated equine oestrogens 1.25 mg daily
Number of subjects: 14

Group type: COMPARATOR
Intervention: Untreated reference group of eight postmenopausal women
Number of subjects: 14
Study: 6255535

Group type: EXPERIMENTAL
Intervention: Ketoconazole (200 mg daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Griseofulvin (250 mg daily)
Number of subjects: 50
Study: 30396226

Group type: EXPERIMENTAL
Intervention: Routine aspirin 75 mg
Number of subjects: 546

Group type: COMPARATOR
Intervention: No aspirin
Number of subjects: 546
Study: 28528242

Group type: EXPERIMENTAL
Intervention: Celecoxib 400mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 26043035

Group type: COMPARATOR
Intervention: Dietary intervention (part of CAFAP)
Number of subjects: 69
Study: 23483886

Group type: EXPERIMENTAL
Intervention: Evening chronotype
Number of subjects: 119
Study: 21629014

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing (EMDR)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 46
Study: 20175428

Group type: EXPERIMENTAL
Intervention: Running trial (60 min, including 15-min warm-up at 75-80% HR(peak) + 45 min at 85-90% HR(peak))
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Running trial (60 min)
Number of subjects: 8
Study: 16570816

Group type: EXPERIMENTAL
Intervention: Intranasal Budesonide (256 microg once daily intranasally for 8 weeks)
Number of subjects: 42
Study: 12808485

Group type: EXPERIMENTAL
Intervention: 10 mg of atorvastatin every day
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 10 mg of atorvastatin every other day
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 20 mg of atorvastatin every other day
Number of subjects: 54
Study: 11892324

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8632574

Group type: EXPERIMENTAL
Intervention: Luteinizing hormone‐releasing hormone agonist therapy for 12 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Immediate radical retropubic prostatectomy
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Analysis by pretreatment PSA levels
Number of subjects: 56
Study: 1999793

Group type: EXPERIMENTAL
Intervention: PCA morphine
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: PCA morphine with low-dose continuous morphine infusion (PCA-plus)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Intramuscularly administered morphine
Number of subjects: 82
Study: 6628007

Group type: EXPERIMENTAL
Intervention: Hygroscopic condensor humidifier (HCH)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional cascade humidification
Number of subjects: 26
Study: 30770850

Group type: EXPERIMENTAL
Intervention: Multi-resolution local binary patterns (MLBP)
Number of subjects: 0
Study: 27332677

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Carotid stenting (CAS)
Number of subjects: 136
Study: 25394822

Group type: EXPERIMENTAL
Intervention: Kin Keeper(SM) Cancer Prevention Intervention, delivered by community health workers, including two cancer education home visits, costing $151/family.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kin Keeper(SM) Cancer Prevention Intervention
Number of subjects: 0
Study: 23630215

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT)
Number of subjects: 1543

Group type: COMPARATOR
Intervention: Observation (OBS)
Number of subjects: 1543
Study: 21642642

Group type: EXPERIMENTAL
Intervention: 0.7 ml kg(‐1) ropivacaine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 1.0 ml kg(‐1) ropivacaine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 1.3 ml kg(‐1) ropivacaine
Number of subjects: 75
Study: 19539813

Group type: EXPERIMENTAL
Intervention: Illness perception intervention (one half‐hour session with a psychologist)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 57
Study: 16934729

Group type: EXPERIMENTAL
Intervention: Backache Index (BAI)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Deep transverse friction myotherapy (after two treatment sessions)
Number of subjects: 75
Study: 15566342

Group type: EXPERIMENTAL
Intervention: Implementation of evidence-based fetal health surveillance guideline
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Guideline recommendations
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Best practice implementation
Number of subjects: 51
Study: 11737959

Group type: EXPERIMENTAL
Intervention: Vitamin A plus Fe supplementation (4800 retinol equivalent vitamin A, 120 mg Fe, and 500 microg folic acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fe supplementation alone (120 mg Fe and 500 microg folic acid)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fe status, weight and length of infants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fe status of girls
Number of subjects: 0

Group type: COMPARATOR
Intervention: Boys
Number of subjects: 0
Study: 9881325

Group type: EXPERIMENTAL
Intervention: 1 mg 17 beta‐oestradiol daily on days 1‐28, combined with either 5 or 10 mg dydrogesterone on days 15‐28 for 12 months (13 cycles of 28 days)
Number of subjects: 154
Study: 7867285

Group type: EXPERIMENTAL
Intervention: Treatment with plasma exchange and immune globulins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 2522007

Group type: EXPERIMENTAL
Intervention: Nicardipine (60 mg daily, for two months)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 17
Study: 31211691

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemia
Number of subjects: 9

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 9
Study: 29262795

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 900 mg once daily for six months
Number of subjects: 980

Group type: COMPARATOR
Intervention: Placebo (similar-looking placebo tablets)
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 980

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 980
Study: 25530306

Group type: EXPERIMENTAL
Intervention: Anger Self-Management Training (ASMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Personal Readjustment and Education (PRE)
Number of subjects: 0
Study: 23767916

Group type: EXPERIMENTAL
Intervention: 800 IU of vitamin D3 per day (low dose)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 4,370 IU of vitamin D3 per day (high dose)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no vitamin D supplementation)
Number of subjects: 45
Study: 21956102

Group type: EXPERIMENTAL
Intervention: 2mg micronized estradiol (E2)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 2mg micronized estradiol and 1mg norethisterone acetate (E2+NETA)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 2.5mg tibolone (T)
Number of subjects: 33

Group type: COMPARATOR
Intervention: No hormone replacement therapy (no HRT)
Number of subjects: 33
Study: 18471588

Group type: EXPERIMENTAL
Intervention: Hand-held computer (PDA) intervention with daily feedback and goal-setting
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard written nutritional education materials (Control)
Number of subjects: 27
Study: 17072706

Group type: EXPERIMENTAL
Intervention: Parker Flex‐Tip tube (PFT)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Standard endotracheal tube (SET)
Number of subjects: 134
Study: 12453903

Group type: EXPERIMENTAL
Intervention: Rosiglitazone (4 mg b.i.d.)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Metformin (1 g b.i.d.)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 10084185

Group type: EXPERIMENTAL
Intervention: Implantable electrical stimulation
Number of subjects: 130

Group type: COMPARATOR
Intervention: Nonstimulated group
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Implantable electrical stimulation (workers' compensation subset)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Nonstimulated group (workers' compensation subset)
Number of subjects: 130
Study: 7672138

Group type: EXPERIMENTAL
Intervention: Octreotide (long‐acting somatostatin analogue) administered SC for 6 weeks
Number of subjects: 20
Study: 1973546

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7412158

Group type: EXPERIMENTAL
Intervention: Methazolamide (oral doses)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Acetazolamide (oral medication)
Number of subjects: 11
Study: 6094444

Group type: EXPERIMENTAL
Intervention: Cefotaxime peroperatively for 24 h
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Ampicillin/tinidazole peroperatively for 24 h
Number of subjects: 201

Group type: COMPARATOR
Intervention: No prophylactic antibiotic
Number of subjects: 201
Study: 30689707

Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg bid)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Chemotherapy treatment of physician's choice (TPC)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 302
Study: 30338823

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (3-4 courses of cisplatin, ifosfamide, and adriamycin)
Number of subjects: 278

Group type: COMPARATOR
Intervention: No chemotherapy (control group)
Number of subjects: 278
Study: 26582310

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study: 24280811

Group type: EXPERIMENTAL
Intervention: Palonosetron-dexamethasone combination (0.075 mg palonosetron and 8 mg dexamethasone)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Palonosetron (0.075 mg)
Number of subjects: 84
Study: 22710099

Group type: EXPERIMENTAL
Intervention: Diet supplementation with olive leaves (10 g/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diet supplementation with α‐tocopheryl acetate (200 mg/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diet supplementation with linseed oil
Number of subjects: 0
Study: 20368558

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus IFN‐alpha
Number of subjects: 732

Group type: COMPARATOR
Intervention: IFN‐alpha monotherapy
Number of subjects: 732
Study: 17585667

Group type: EXPERIMENTAL
Intervention: Acupuncture regulating the Governor vessel (Fengfu (GV 16), Dazhui (GV 14), Baihui (GV 20), etc.)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Routine acupuncture at Jiaji points (C3 - C7 Jiaji points (EX-B 2) and Fengchi (GB 20))
Number of subjects: 98
Study: 15619462

Group type: EXPERIMENTAL
Intervention: Unsupported drawing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supported drawing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Freehand spirals
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dominant hand drawing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Effort levels (normal, slow, soft, rapid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inter-rater and intra-rater reliability for unsupported drawings
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inter-rater and intra-rater reliability for freehand drawings
Number of subjects: 0
Study: 11934082

Group type: EXPERIMENTAL
Intervention: 12-week smoking cessation program plus a 3-times-per-week exercise program
Number of subjects: 281

Group type: COMPARATOR
Intervention: Contact control wellness program
Number of subjects: 281
Study: 10075324

Group type: EXPERIMENTAL
Intervention: 10% fat diet (2.7% saturates) for 10 days
Number of subjects: 38

Group type: COMPARATOR
Intervention: 20-24% fat diets
Number of subjects: 38
Study: 8635032

Group type: EXPERIMENTAL
Intervention: Interactive multimedia program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Brochure
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Patient-centered behavior by physicians
Number of subjects: 60
Study: 2206836

Group type: EXPERIMENTAL
Intervention: diclofenac gel (Voltarol Emulgel) 4 g tds
Number of subjects: 384

Group type: COMPARATOR
Intervention: felbinac gel (Traxam) 4 g tds
Number of subjects: 384
Study: 6108335

Group type: EXPERIMENTAL
Intervention: Ketazolam (once-daily)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Ketazolam (three-times-daily)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 31159837

Group type: EXPERIMENTAL
Intervention: Hybrid fixation (using ESIN for the radius and ORIF for the ulna)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Double plate fixation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hybrid fixation
Number of subjects: 0
Study: 29535271

Group type: EXPERIMENTAL
Intervention: Utility-weighted modified Rankin Scale (UW-mRS)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Dichotomous mRS approach
Number of subjects: 500

Group type: COMPARATOR
Intervention: Ordinal mRS approach
Number of subjects: 500
Study: 26715227

Group type: EXPERIMENTAL
Intervention: Zopiclone (7.5 mg)
Number of subjects: 12
Study: 25018069

Group type: EXPERIMENTAL
Intervention: Individualized scan delay of 20 seconds
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Individualized scan delay of 30 seconds
Number of subjects: 150
Study: 23049924

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate treatment
Number of subjects: 494

Group type: COMPARATOR
Intervention: Folinate rescue therapy
Number of subjects: 494
Study: 19734013

Group type: EXPERIMENTAL
Intervention: Task-switching performance under high context demands
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Task-switching performance under low context demands
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Context processing deficits in schizophrenia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Influence of PFC impairments on task-switching performance
Number of subjects: 0
Study: 16988651

Group type: EXPERIMENTAL
Intervention: Arabinoxylan (AX) supplement 15 g
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 16269401

Group type: EXPERIMENTAL
Intervention: ASA 150 mg daily and Low Molecular Weight Heparin (LMWH) 5000 IU x2 for three days
Number of subjects: 14

Group type: COMPARATOR
Intervention: Acetyl salicylic acid (ASA) 150 mg daily
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Postoperative treatment
Number of subjects: 14
Study: 14675849

Group type: EXPERIMENTAL
Intervention: New drug treatment
Number of subjects: 0
Study: 10520100

Group type: EXPERIMENTAL
Intervention: Subcutaneous patient‐controlled analgesia (PCA) (bolus dose 2.5 mg diamorphine in 1 ml with a 20‐minute lockout)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intravenous patient‐controlled analgesia (PCA) (bolus dose 0.5 mg diamorphine in 1 ml with a 5‐minute lockout)
Number of subjects: 100
Study: 7743764

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 1963127

Group type: EXPERIMENTAL
Intervention: Surgical method A for reattaching the retina
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical method B for reattaching the retina
Number of subjects: 0
Study: 7212331

Group type: EXPERIMENTAL
Intervention: N2O:O2 combined with fentanyl (n = 20)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: enflurane (n = 24)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: halothane (n = 23)
Number of subjects: 67
Study: 29623407

Group type: COMPARATOR
Intervention: HOT (33 °C, 8-h sleep opportunity)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: HOT+SR (33 °C, 4-h sleep opportunity)
Number of subjects: 31
Study: 27102200

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Alcohol intake
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: CYP19A1 polymorphisms
Number of subjects: 25
Study: 24559097

Group type: EXPERIMENTAL
Intervention: Individualised pre-performance routines (PPRs)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 20
Study: 23248037

Group type: EXPERIMENTAL
Intervention: Pregabalin (PGB) add-on therapy
Number of subjects: 25
Study: 18845036

Group type: EXPERIMENTAL
Intervention: Type one tympanoplasty along with cortical mastoidectomy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Type one tympanoplasty alone
Number of subjects: 68
Study: 18087553

Group type: COMPARATOR
Intervention: Enalapril 10.0 mg/d
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Enalapril 10.0 mg + Folic acid 0.4 mg/d
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Enalapril 10.0 mg + Folic acid 0.8 mg/d
Number of subjects: 480